March 27, 2007 (New Orleans) — Heart attack patients are more likely to
survive for years longer than in the past, thanks to increased use of potent
heart medications that control long-term risks, researchers report.
Growing use of cholesterol-lowering statin drugs and high blood pressure
drugs helped to lower death rates among heart attack patients by a significant
3% per year from 1995 to 2004, says Soko Setoguchi, MD, a researcher at Brigham
and Women’s Hospital in Boston.
Cardiovascular disease is still the No. 1 killer in the United States, and
865,000 people have a heart attack each year. But the new findings show that
drug therapy can make a difference, says Douglas P. Zipes, MD, director of
cardiology at Indiana University School of Medicine in Indianapolis.
While death rates are going down, a worsening tide of obesity, inactivity,
and diabetes are all contributing to an increased risk of having a heart
attack, says Zipes, who was not involved with the study.
The new findings emphasize the importance of pharmacological regimens, he
tells WebMD. Patients should take their medications as prescribed by their
cardiologists because there are very real benefits, including living
longer.
The study was presented at the annual meeting of the American College of
Cardiology.
Use of Statins, High Blood Pressure Drugs Up
For the study, Setoguchi and colleagues tracked nearly 22,000 people who
were hospitalized for a heart attack between 1995 and 2004 and survived at
least 30 days after discharge. They were followed for an average of 3.5 years,
during which time about half of them died.
Analysis of pharmacy records showed that the use of heart drugs also
increased during the study period:

The use of statin drugs rose from about 8% in 1995 to 45% in 2004. Statins
treat high cholesterol and include drugs such as Crestor, Lipitor, Pravachol,
and Zocor.
The use of beta-blockers, which include drugs such as Coreg and Toprol-XL,
rose from 41% in 1995 to 65% in 2004. They help the heart relax, slow the heart
rate, and lower blood pressure, thereby boosting the heart’s pumping ability
over time.
The use of angiotensin-converting enzyme (ACE) inhibitors such as Altace
and Captopril and angiotensin II receptor blockers (ARBs) such as Diovan
increased from 40% to 45%. These drugs are widely prescribed to patients
following heart attacks and for those with heart failure. They are high blood
pressure drugs, which work by preventing blood vessels from narrowing, making
it easier for blood to flow through the vessels and alleviating the workload on
the heart.

Drugs Boosting Survival
When the researchers took drug therapy into account, the decrease in deaths
over time was entirely eliminated. This suggests that the change in survival
is primarily attributable to increased use of recommended drugs, Setoguchi
says.
More heart attack survivors also underwent angioplasty and stenting to prop
up blocked heart arteries over time, she says.
When the researchers took those figures into account, the reduction in
deaths diminished but wasnt entirely eliminated, Setoguchi says. The
increased use of angioplasty and other interventions couldnt explain the
improvement in long-term survival, she tells WebMD.
That may be because the researchers only looked at heart attack patients who
survived their hospital stay. Another analysis, which looked at death rates
among heart attack patients during hospitalization, showed that an increased
use in angioplasty accounted for a similar rise in early survival rates, she
says.
Because many people in the study were on more than one medication, Setoguchi
says the researchers couldnt determine the relative impact of each type of
drug on survival rates.

source